CARBOHYDRATE METABOLISM DISTURBANCES: THERAPEUTIC POTENTIAL IN METABOLIC SYNDROME
The study was focused on dibicor effects on carbohydrate metabolism (CM) and insulin resistance (IR) in patients with metabolic syndrome (MS), as well as the correlations between various CM parameters, chronic heart failure (CHF), and abdominal obesity (AO). In total, 61 patients aged 31–66 years ga...
Main Authors: | I. V. Kryuchkova, A. S. Adamchik |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2009-04-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1336 |
Similar Items
-
MEXICOR EFFECTIVENESS IN PATIENTS WITH CHRONIC HEART FAILURE AND METABOLIC SYNDROME
by: M. E. Statsenko, et al.
Published: (2009-12-01) -
Taurin in combined treatment of metabolic syndrome and diabetes mellitus
by: Aleksandr Sergeevich Ametov, et al.
Published: (2011-10-01) -
CARDIONATE IN COMBINED THERAPY OF ISCHEMIC CHRONIC HEART FAILURE AMONG PATIENTS WITH METABOLIC SYNDROME
by: M. E. Statsenko, et al.
Published: (2010-08-01) -
NEW POTENTIAL OF MEXICOR IN THE TREATMENT OF CHRONIC HEART FAILURE AMONG PATIENTS WITH METABOLIC SYNDROME
by: M. E. Statsenko, et al.
Published: (2010-12-01) -
Taurine effects on 24-hour blood pressure monitoring parameters in patients with chronic heart failure and metabolic syndrome
by: I. V. Kryuchkova, et al.
Published: (1970-01-01)